A detailed history of Caption Management, LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Caption Management, LLC holds 46,162 shares of AGIO stock, worth $1.97 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
46,162
Previous 27,500 67.86%
Holding current value
$1.97 Million
Previous $1.19 Million 73.0%
% of portfolio
0.04%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$41.19 - $49.72 $1.9 Million - $2.3 Million
46,162 New
46,162 $2.05 Million
Q1 2023

May 15, 2023

BUY
$21.74 - $30.93 $88,829 - $126,379
4,086 New
4,086 $93,000
Q2 2022

Aug 15, 2022

SELL
$17.06 - $31.42 $324,140 - $596,980
-19,000 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$26.68 - $34.81 $586,960 - $765,820
-22,000 Reduced 53.66%
19,000 $552,000
Q4 2021

Feb 11, 2022

BUY
$29.58 - $49.78 $1.21 Million - $2.04 Million
41,000 New
41,000 $1.35 Million
Q3 2021

Nov 12, 2021

SELL
$41.92 - $58.18 $796,480 - $1.11 Million
-19,000 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$52.06 - $61.27 $3.07 Million - $3.61 Million
-59,000 Reduced 75.64%
19,000 $1.05 Million
Q1 2021

May 17, 2021

BUY
$44.23 - $57.5 $1.37 Million - $1.78 Million
31,000 Added 65.96%
78,000 $4.03 Million
Q4 2020

Feb 16, 2021

BUY
$33.21 - $46.54 $531,360 - $744,640
16,000 Added 51.61%
47,000 $2.04 Million
Q3 2020

Nov 16, 2020

BUY
$33.87 - $55.93 $508,049 - $838,950
15,000 Added 93.75%
31,000 $1.09 Million
Q2 2020

Aug 14, 2020

SELL
$34.45 - $53.48 $895,700 - $1.39 Million
-26,000 Reduced 61.9%
16,000 $856,000
Q1 2020

May 15, 2020

SELL
$31.52 - $53.81 $47,280 - $80,715
-1,500 Reduced 3.45%
42,000 $1.49 Million
Q4 2019

Feb 13, 2020

SELL
$30.08 - $50.59 $2.14 Million - $3.6 Million
-71,100 Reduced 62.04%
43,500 $2.08 Million
Q3 2019

Nov 14, 2019

BUY
$32.4 - $49.58 $3.71 Million - $5.68 Million
114,600 New
114,600 $3.71 Million

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $2.34B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.